Clinical trial
Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
NCT03597412
Study timeline
Study start (actual)2018-10-17Date precision: day
Registry last updated2020-12-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Atherosclerotic Cardiovascular Diseaseunresolved
Type 2 Diabetes Mellitusunresolved
Interventions
RosuvamibeDRUG
MonorovaDRUG
Sponsors & collaborators
Yuhan Corporationlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03597412 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.